Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Agreement

21 Mar 2018 16:26

RNS Number : 5025I
Interserve PLC
21 March 2018
 

 

 

 

21 March 2018

 

UPDATE ON REFINANCING

 

Interserve announces that discussions with lenders and other financial stakeholders have continued to progress well, with agreement in principle on major commercial terms now reached. These commercial terms remain subject to credit approval from all providers before the new facilities are finalised. In addition, the lenders have agreed to extend the covenant test deferral date and the maturities of the financing facilities agreed in December 2017 to 30 April 2018 to enable the successful execution of all documentation required for the refinancing.

 

The additional facilities comprise cash facilities of £196.6m plus bonding facilities of up to £95m. These new facilities will mature in September 2021. Existing debt and private placement loan notes will be amended to be co-terminous with the new facilities. Borrowings made under the incremental short-term facilities agreed in December 2017 and which now expire on 30 April 2018 (under which the Company has drawn £45m of the revolving credit facility) will be repaid out of the new facilities, once these are in place. In total, this means that the company will have cash borrowing facilities of £834m immediately following the refinancing completion and through to September 2021, subject to certain step-downs in the new facilities over the period.

 

Pricing on both the new facilities, and the existing debt and bonding facilities have been renegotiated as part of the refinancing. It is anticipated that the total interest expense in 2018 will be approximately £56m of which circa £34m will be cash interest. The increased cost of bonding instruments already issued will be circa £3.2m, of which the cash impact is less than £1m.

 

Additionally, as part of the proposed deal terms, the company anticipates that it will issue warrants to the providers of the new cash and bonding facilities to buy shares at 10 pence per share (the nominal price of each share). If exercised, this would provide the warrant holders with an interest of up to 20% of the post-issue share capital.

 

We have, as part of this process, engaged extensively with the Trustee of the Interserve section of the Interserve Pension Scheme with respect to the new refinanced structure and their security protection. This has been agreed with them, subject to the finalisation of the required documentation.

 

 

Debbie White, Interserve's Chief Executive, said:

 

"Today's announcement is a significant milestone for Interserve and a major step in securing a firm financial platform to underpin the Group's future. We are encouraged by the support from our lenders in respect of these new facilities, which will allow the new management team to execute our business plan, focused on delivering a great service for customers, driving growth and restoring value."

 

Ends

 

 

 

Contact details:

Robin O'Kelly, Director of Communications +44 (0) 7786 702526

Rhys Jones, Head of PR, Interserve +44 (0) 7909 605336

Martin Robinson, Tulchan Communications +44 (0) 20 7353 4200

 

This announcement contains inside information

LEI: 549300MVYY4EZCRFHZ09

Classification: Inside information

 

About Interserve

 

Interserve is one of the world's foremost support services and construction companies. Our vision is to redefine the future for people and places. Everything we do is shaped by our core values. We are a leader in innovative and sustainable outcomes for our clients and a great place to work for our people. We offer advice, design, construction, equipment, facilities management and frontline public services. We are headquartered in the UK and listed in the FTSE. We have gross revenues of £3.7 billion and a workforce of circa 80,000 people worldwide.

www.interserve.com

 

For news follow @interservenews

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRSEDFMFFASEED
Date   Source Headline
9th Sep 20163:37 pmRNSDirector/PDMR Shareholding
25th Aug 20169:33 amRNSPublication of Half-Year Report 2016
24th Aug 20167:00 amRNSCONTRACT WIN
10th Aug 20167:00 amRNSHalf-Year Results
9th Aug 201610:59 amRNSDirector/PDMR Shareholding
8th Aug 20167:00 amRNSContract Extension
5th Aug 20162:19 pmRNSHolding(s) in Company
15th Jul 20163:31 pmRNSHolding(s) in Company
12th Jul 20162:47 pmRNSDirector/PDMR Shareholding
1st Jul 20163:21 pmRNSBlock listing Interim Review
28th Jun 20167:00 amRNSContract Win
14th Jun 20161:04 pmRNSDirector/PDMR Shareholding
27th May 20163:51 pmRNSDirector/PDMR Shareholding
26th May 20163:48 pmRNSDirector/PDMR Shareholding
18th May 20167:00 amRNSContract Win
16th May 20162:32 pmRNSDirector/PDMR Shareholding
13th May 20168:38 amRNSHolding(s) in Company
10th May 20162:46 pmRNSResult of AGM
10th May 20167:00 amRNSDirector/PDMR Shareholding
6th May 20167:00 amRNSTrading Update
5th May 20167:00 amRNSBoard Change
3rd May 20167:00 amRNSContract Win
27th Apr 20163:33 pmRNSDirector Declaration
19th Apr 20163:26 pmRNSDirector/PDMR Shareholding
18th Apr 20167:00 amRNSContract Win
14th Apr 20163:25 pmRNSDirector/PDMR Shareholding
13th Apr 20164:16 pmRNSDirector/PDMR Shareholding
6th Apr 20164:48 pmRNSDirector/PDMR Shareholding
31st Mar 201610:23 amRNSDirector/PDMR Shareholding
31st Mar 20169:18 amRNSTotal Voting Rights
30th Mar 20168:36 amRNSPublication of Annual Report
22nd Mar 20163:13 pmRNSAdditional Listing
9th Mar 201610:46 amRNSDirector/PDMR Shareholding
29th Feb 201610:51 amRNSHolding(s) in Company
24th Feb 20167:00 amRNSFinal Results
10th Feb 201612:11 pmRNSDirector/PDMR Shareholding
4th Feb 20164:51 pmRNSHolding(s) in Company
2nd Feb 20169:59 amRNSCirc re Adoption of FRS 101
14th Jan 201610:38 amRNSDirector/PDMR Shareholding
4th Jan 20167:00 amRNSBlocklisting Interim Review
17th Dec 20154:13 pmRNSDirector/PDMR Shareholding
3rd Dec 20151:54 pmRNSHolding(s) in Company
30th Nov 20154:21 pmRNSHolding(s) in Company
13th Nov 20157:05 amRNSAppointment of Chairman-Designate
13th Nov 20157:00 amRNSQ3 Trading Update
10th Nov 20152:05 pmRNSDirector/PDMR Shareholding
5th Nov 20152:02 pmRNSHolding(s) in Company
27th Oct 20152:13 pmRNSDirector/PDMR Shareholding
15th Oct 20159:21 amRNSDirector/PDMR Shareholding
14th Oct 201510:29 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.